Author Topic: NARCOMS study results comparing disability worsening in patients on Tecfidera, Gilenya  (Read 38 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
From Therapeutic Advances in Neurological Disorders (June 30, 2021)--"A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod":


https://journals.sagepub.com/doi/full/10.1177/17562864211021177
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
121 Views
Last post March 25, 2016, 06:13:56 am
by agate
0 Replies
182 Views
Last post April 21, 2016, 05:17:20 pm
by agate
0 Replies
171 Views
Last post January 19, 2018, 04:50:41 pm
by agate
0 Replies
161 Views
Last post June 08, 2018, 09:02:03 pm
by agate
0 Replies
142 Views
Last post June 08, 2018, 09:06:06 pm
by agate